These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19146417)

  • 61. Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7).
    Urbano M; Guerrero M; Zhao J; Velaparthi S; Saldanha SA; Chase P; Wang Z; Civelli O; Hodder P; Schaeffer MT; Brown S; Rosen H; Roberts E
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7135-41. PubMed ID: 23079522
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of potent and selective small-molecule PAR-2 agonists.
    Seitzberg JG; Knapp AE; Lund BW; Mandrup Bertozzi S; Currier EA; Ma JN; Sherbukhin V; Burstein ES; Olsson R
    J Med Chem; 2008 Sep; 51(18):5490-3. PubMed ID: 18720984
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
    Humphries PS; Benbow JW; Bonin PD; Boyer D; Doran SD; Frisbie RK; Piotrowski DW; Balan G; Bechle BM; Conn EL; Dirico KJ; Oliver RM; Soeller WC; Southers JA; Yang X
    Bioorg Med Chem Lett; 2009 May; 19(9):2400-3. PubMed ID: 19346127
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
    Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
    J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discovery and optimization of a novel Neuromedin B receptor antagonist.
    Fu J; Shuttleworth SJ; Connors RV; Chai A; Coward P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4264-7. PubMed ID: 19553112
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series.
    Sisay MT; Peltason L; Bajorath J
    J Chem Inf Model; 2009 Oct; 49(10):2179-89. PubMed ID: 19761254
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate.
    Westaway SM; Brown SL; Fell SC; Johnson CN; MacPherson DT; Mitchell DJ; Myatt JW; Stanway SJ; Seal JT; Stemp G; Thompson M; Lawless K; McKay F; Muir AI; Barford JM; Cluff C; Mahmood SR; Matthews KL; Mohamed S; Smith B; Stevens AJ; Bolton VJ; Jarvie EM; Sanger GJ
    J Med Chem; 2009 Feb; 52(4):1180-9. PubMed ID: 19191554
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Virtual screening - what does it give us?
    Köppen H
    Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Syntheses of tetrahydrothiophenes and tetrahydrofurans and studies of their derivatives as melanocortin-4 receptor ligands.
    Tran JA; Chen CW; Tucci FC; Jiang W; Fleck BA; Chen C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1124-30. PubMed ID: 18082401
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The design and implementation of a generic lipopeptide scanning platform to enable the identification of 'locally acting' agonists for the apelin receptor.
    McKeown SC; Zecri FJ; Fortier E; Taggart A; Sviridenko L; Adams CM; McAllister KH; Pin SS
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4871-5. PubMed ID: 25241924
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation.
    Casadó V; Ferrada C; Bonaventura J; Gracia E; Mallol J; Canela EI; Lluís C; Cortés A; Franco R
    Biochem Pharmacol; 2009 Dec; 78(12):1456-63. PubMed ID: 19643089
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure-based design of molecular cancer therapeutics.
    van Montfort RL; Workman P
    Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
    Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARdelta agonists.
    Zhang R; Deangelis A; Wang A; Sieber-McMaster E; Li X; Russell R; Pelton P; Xu J; Zhu P; Zhou L; Demarest K; Murray WV; Kuo GH
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1101-4. PubMed ID: 19168353
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor.
    Batuwangala M; Camarda V; McDonald J; Marzola E; Lambert DG; Ng LL; Calo' G; Regoli D; Trapella C; Guerrini R; Salvadori S
    Peptides; 2009 Jun; 30(6):1130-6. PubMed ID: 19463746
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Yeast assays for G protein-coupled receptors.
    Dowell SJ; Brown AJ
    Methods Mol Biol; 2009; 552():213-29. PubMed ID: 19513652
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
    Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
    Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.
    Grieco P; Carotenuto A; Campiglia P; Gomez-Monterrey I; Auriemma L; Sala M; Marcozzi C; d'Emmanuele di Villa Bianca R; Brancaccio D; Rovero P; Santicioli P; Meini S; Maggi CA; Novellino E
    J Med Chem; 2009 Jul; 52(13):3927-40. PubMed ID: 19432421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.